Daniel J. O'Connor, CEO & President at ONCOSEC MEDICAL Inc (ONCS), bought 10,000 shares at $0.91 ($9K) on 2018-11-07, disclosed to the SEC on 2018-11-07.
Open-market purchase of $9k ONCS by CEO & President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| ONCS | SELL | 2021-05-04 | $15K | — | Filing → |
| ONCS | SELL | 2021-02-02 | $26K | — | Filing → |
| ONCS | SELL | 2020-11-03 | $12K | — | Filing → |